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Background/aim: We aimed to determine in which cases this procedure may be more effective based on the data of patients who
underwent decompressive hemicraniectomy (DHC).
Material and methods: Overall, 47 patients who underwent DHC due to acute middle cerebral artery (MCA) infarction between
January 2014 and january 2019 were retrospectively investigated. These patients were divided into two groups: those who died after
DHC (Group A) and those who survived DHC (Group B). The groups were compared in terms of various parameters. We investigated
whether the patient’s modified Rankin scale (mRS) status changed depending on age (> 60 and < 60 years).
Results: The median age of all patients was 65 (37–80) years; groups A and B had median ages of 66.5 (37–80) and 61 (44–79) years (p
= 0.111), respectively; 55.3% patients were male. The elapsed times until hospitalization after the onset of symptoms were 4.5 and 3 h
in groups A and B, respectively (p = 0.014). The median GCS score at the time of admission was 7 (5–12) and 10 (8–14) in groups A
and B, respectively (p = 0.0001). At the time of admission, 63.3% patients in group A had anisocoria, whereas no patient in group B had
anisocoria (p = 0.0001). In postoperative period, 40% patients in group A and all patients in group B received AC/AA treatment. The
survival of patients aged < 60 and > 60 years who underwent DHC for MCA infraction was 61.5% and 26.5%, respectively (p = 0,041).
The median mRS of patients < 60 and > 60 years were 4 (1–6) and 6 (1–6), respectively (p = 0.018).
Conclusion: Age, DHC timing, and elapsed time until hospitalization or access to treatment directly affect the functional outcome and
survival in MCA-infarcted patients who underwent DHC. In patients in whom the medical treatment fails, early DHC administration
will increase survival without waiting for neurological worsening once herniation is detected radiologically.
Key words: Decompressive hemicraniectomy, stroke, middle cerebral artery

1. Introduction
Decompressive hemicraniectomy (DHC) is an auxiliary
intervention to treat high intracranial pressure (ICP)
caused by acute stroke and traumatic brain injuries. The
nutrition and oxygenation of the brain are disturbed
in acute stroke where cerebral blood perfusion (CBP)
decreases [1,2]. Morbidity or death caused by herniation
and cerebral edema can be prevented because of DHC.
The treatment of severe cerebral infarction and large
cerebral edema caused by acute stroke is one of the most
controversial neurovascular phenomena. Such severe
cerebral infarctions occur in 1%–10% of all supratentorial
infarctions [3]. Cerebral edema due to acute stroke may
lead to herniation and eventually mortality or morbidity
despite antiaggregant thrombolytic therapy or mechanical

thrombectomy administered during the first 24 h [4,5].
Therefore, early DHC is recommended to reduce ICP
and achieve better functional results [4]. Ipsilateral DHC
after an acute stroke caused by a thrombus of the middle
cerebral artery (MCA) was first reported in 1956 [6]. DHC
can help with brain decompression, prevent herniation
and play a life-saving role by increasing CBP. Most patients
are discharged with a severe disability although the risk of
mortality in patients with MCA infarction decreases with
DHC [7].
In this study, we examined the patients who underwent
DHC due to progressive cerebral edema because they
did not respond to aggressive medical treatment after
MCA infarction, were not suitable for thrombectomy, or
because of failed thrombectomy. We divided the patients
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with MCA infarction who survived and died despite
DHC administration into two groups. We investigated the
factors affecting survival and functional recovery based on
the different characteristics of the groups.
2. Materials and methods
Patients who underwent DHC at our clinic between
January 2014 and January 2019 due to increased ICP
caused by different etiologies and related neurological
worsening were retrospectively investigated. Data of the
patient were collected using hospital data and archiving
system. Patients who were unable to visit the hospital
for regular follow-up were called by phone. We included
only cases of acute MCA infarction in which DHC was
used to reduce ICP elevation. The patients included in
the study were admitted to the Neurology Intensive Care
Unit (NICU) after their emergency service admissions.
They were followed up at the NICU after DHC procedure.
Patients with MCA infarction who underwent DHC were
divided into two groups: deceased patients (group A)
and surviving patients (group B). The outcomes and post
discharge data of patients in group B were collected from
their files and through phone calls.
2.1. Parameters
The two groups were compared in terms of age, sex, systemic
diseases; prior use of anticoagulants and antiaggregants
(AC/AA) treatments, admission complaints, elapsed
time until hospitalization after the onset of symptoms;
Glasgow Coma Scale (GCS) score at admission, presence
of anisocoria at the time of admission, application of tissue
plasminogen activator (tPA); the success of thrombectomy
during the preoperative period, preoperative and
postoperative AC/AA treatments, DHC decision-making
criteria (clinical deterioration, radiological deterioration
or both); the presence of constraints and/or blood on
presurgical brain computed tomography (CT), presence
of anisocoria at the time of DHC, elapsed time from
admission to DHC (DHC time); the side that DHC
was applied, performance of duraplasty and hematoma

evacuation during the surgical procedure and presence
of blood on the postoperative CT and at the follow-up
period. All patients were followed by preoperative and
postoperative CT. Group B was evaluated according to the
discharge modified Rankin scale (mRS) (Table 1) [8,9],
outpatient follow-up period and cranioplasty time. We
also investigated if the mRS score and outcomes of patients
varied depending on age (> 60 and < 60 years) and the side
of pathology (right and left MCA infarction).
2.2. Data analysis
Data were analyzed using the SPSS package software
program (Version 17.0, SPSS Inc., Chicago, IL,
USA). Normality was analyzed with the Kolmogorov–
Smirnov and Shapiro–Wilk tests and histograms for each
continuous variable. All numerical data were expressed
in median values (minimum-maximum), and categorical
variables were described as proportions. The categorical
variables between the groups were analyzed with the Chi
square or Fisher’s exact tests. The groups were compared
using the Mann–Whitney U test for the non-normally
distributed data. A p value <0.05 was considered significant.
3. Results
3.1. Participants
A total of 67 patients underwent DHC for increased
ICP due to different etiologies and related neurological
deterioration. Forty-seven patients were included who
underwent DHC due to ICP elevation resulting from
malignant MCA infarction, which could not be avoided
despite medical and interventional treatment. Those who
underwent DHC for tumors, trauma and etiologies other
than acute stroke were not included in the study. The
patients were divided into two groups: group A (deceased
patients, n = 30) and group B (surviving patients, n = 17).
3.2. Age, sex, comorbidities, medicines and complaints
The median age of all patients was 65 (37–80) years. The
median ages of the A and B groups were 66 (37–80) and 61
(44–79) years, respectively; it was insignificant (p = 0.111).
The majority of patients were male (55.3%), and there was

Table 1. Modified Rankin scale (mRS) (24.22).
Score

Description

0

No symptoms at all

1st

No significant disability despite symptoms, able to perform usual duties and activities

2nd

Slight disability, unable to perform all previous activities but able to look after own affairs without assistance

3rd

Moderate disability, requiring some help but able to walk without assistance

4th

Moderately severe disability, unable to walk without assistance and unable to attend own needs without assistance

5th

Severe disability, bedridden, incontinent and requiring constant nursing care and attention

6th

Dead
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no significant difference between the groups in terms of
sex (group A: male, 53.3%; female, 46.7% and group B:
male, 58.8%; female, 41.2%; Table 2). The most common
reason for admission was hemiparesis/hemiplegia (45.9%)
followed by impaired consciousness (37.93%) and speech
impairment (16.09%).
The most common systemic diseases were hypertension
(HT) in 80.9%, coronary artery disease (CAD) in 27.7%,
diabetes mellitus (DM) in 27.7% and atrial fibrillation
(AF) in 25.53%. The groups’ HT rates were similar, and
they were not significant (p = 0.704), 88.2% of group B
did not have DM (p = 0.094). Additionally, 23 (48.93%)
patients were using at least one of the AC/AA medications
such as dabigatran etexilate, apixaban, clopidogrel,
warfarin sodium and acetylsalicylic acid (ASA) due to
previous systemic or recovered diseases. Hence, there was
no difference between the groups (p = 0.912) (Table 2).
3.3. Arrival and surgery times
Overall, 74.5% of patients were referred from other
healthcare centers to our clinic. The arrival time of
patients to our center since the onset of symptoms was
4.5 h in Group A and 3 h in Group B. This parameter was
significant between the groups (p = 0.014). The median
surgery time after the onset of symptoms was 44 h (4–480)
in all patients. This parameter was not significant, and
both groups were operated in 42 and 48 h on average,
respectively (p = 0.991, Table 2).
3.4. Neurological status
All patients were evaluated based on their GCS scores and
the presence of anisocoria at the time of admission to our

hospital. The median GCS score at the time of admission
was 8 (5–14) and 40.8% of the patients had anisocoria.
The median GCS score at the time of admission was 7
(5–12) and 10 (8–14) in groups A and B, respectively and
it was significant (p = 0.0001). At the time of admission,
no one in group B had anisocoria, while 63.3% of the
patients in group A did. At the time of surgery, anisocoria
was present in 83.3% and 47.1% of patients in groups A
and B, respectively (Table 3). Anisocoria assessments at
the times of hospital admission and surgical treatment
were significant between the groups (p = 0.0001 and p =
0.018, respectively).
3.5. Radiology
All patients underwent CT examinations upon admission
to our hospital and NICU. Right MCA infarction was
observed in 55.3% of the patients, and both groups
had similar rates (56.7% and 52.9%, respectively) (p =
1.000). Radiological herniation findings were observed
in 96.3% (n = 44) of the patients. The patients had uncal
and subfalcine herniation or both (96,7% and 88.2%
of patients in groups A and B, respectively, p = 0.059).
Intracerebral hematoma or subarachnoid hemorrhage
were observed in 61.7% (n = 29) of patients. Although it
was not significant, 73.3% and 41.2% of patients in groups
A and B had intracerebral hematoma or subarachnoid
hemorrhage on CT, respectively (p = 0.544) (Table 3). Six
patients (5 in Group A and 1 in Group B) were operated
on with DHC due to intracerebral hematoma (Figures
1A, 1B). They were treated with surgical evacuation
(Figure 1C).

Table 2. Comparison of the groups in terms of age, sex, history of systemic disease, anticoagulant or antiaggregant use, arrival time to
the hospital, and surgical timing parameters.

Age
(years)
(p = 0.111)
(median(min-max))

Group A
(n = 30)

Group B
(n = 17)

66.5
(37–80)

61
(44–79)

Sex
(p = 0.768)
(%)

M: 53.3
F: 46.7

M: 58.8
F: 41.2

Comorbidities (%)
HT(p = 0.704)
CAD(p = 0.500)
DM(p = 0.094)
AC/AA(p = 0.912)

Arrival time to the
hospital (hour)
(p = 0.014)
(median(min-max))

HT: 83.3
CAD: 23.3
DM: 36.7
AC/AA: 46

4.5
(1–120)

HT: 76.5
CAD: 35.3
DM: 11.8
AC/AA: 52.94

3
(1–8)

DHC Timing
(hour)
(p = 0.991)
(median(min-max))

42
(4–480)

48
(6–144)

*AC/AA: Anticoagulant and Antiaggregant, CAD: Coronary artery disease, DHC: Decompressive Hemicraniectomy, DM: Diabetes
Mellitus, HT: Hypertension, F:Female M:Male.
Note: The values were presented as median (min-max) and n (%).
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Table 3. Comparison of the groups in terms of anisocoria and GCS at the first examination, preoperative anisocoria, side of pathology,
and CT findings.
Anisocoria
(at first examination)
(p = 0.0001)
(%)

GCS
(at first examination)
(p = 0.0001)
(median(min-max))

Anisocoria
(Preoperative)
(p = 0.018)
(%)

Side of pathology
(p = 1.000)
(%)

Group A
(n = 30)

63.3

7
(5–12)

83.3

Right: 56.7
Left: 43.3

Group B
(n = 17)

0

10
(8–14)

47.1

Right: 52.9
Left: 47.1

Preoperative CT
(B and H)
(p = 0.544, p = 0.059)
(%)
B: 73.3
H: 96.7
B: 41.2
H: 88.2

*B: Blood, H: Herniation, GCS: Glasgow coma scale.
Note: The values were presented as median (min-max) and n (%).

Figure 1. A patient with right MCA infarction. A: Early MRI findings. B: Intracerebral hematoma and subfalcin herniation on CT 24 h
after admission. C: CT findings after DHC and hematoma evacuation. *DHC: Decompressive hemicraniectomy, MCA: Middle cerebral
artery, CT: Computed tomography, MRI: Magnetic resonance image.

3.6. tPA and thrombectomy
tPA was used in 38.3% of patients during the preoperative
period, and it was not different between the groups
(groups A: 33.3% and B: 47.1%, p = 0.371). Moreover,
46.7% and 5.9% of patients in groups A and B, respectively
underwent thrombectomy with endovascular intervention
during the preoperative period and it was significant (p =
0.004, Table 4).
3.7. Anticoagulant and antiaggregant treatment
Patients were examined in terms of their preoperative
and postoperative AC/AA treatments in the NICU. The
treatment regimens provided during the preoperative
period did not differ between the groups (p = 0.363) and
AC/AA treatment was administered to all patients in group

2060

B during the postoperative period. Approximately 40% of
group A did not receive this treatment due to increased
risk of postoperative bleeding or existing bleeding, which
was observed in both groups, and it was significant (p =
0.023, Table 4). The most preferred treatment during the
postoperative period was the combined administration of
low-molecular-weight heparin and ASA to 40% and 58.5%
of patients in groups A and B, respectively.
3.8. Surgery
The criteria for the choice of the surgical treatment were
evaluated. DHC was assessed based on the clinical and
radiological statuses of the patients. Surgical treatment
was deemed appropriate for the 14.9% of patients for
neurological deterioration (sudden decrease of 2 or
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more points in GCS) and in 31.9% due to worsening in
the radiological findings, and there was no significant
difference between the groups. DHC was performed as
standard on the side of pathology in all patients with an
average size of 15 × 15 cm to cover the frontal, parietal
and temporal lobes, and the dura was opened. The median
operative time in all patients was 75 (60–150) min and
there was no significant difference (group A: 75 (60–150)
min and group B: 90 (60–120) min). Six patients (12.8%)
had hematoma evacuation. Further, 70.6% and 56.7% of
patients in groups B and A, respectively did not undergo
duraplasty (with allograft or autograft). Three patients
(two patients in group A and one in group B; 6.38%)
were re-operated due to wound complications during the
postoperative follow-up.
3.9. The follow-up
The medical treatments were continued in NICU during
the follow-up. The median postoperative follow-up time
of patients in group A who died despite the medical and
surgical treatments targeting malignant MCA infarction

was 10.5 (1–72) days. The median discharge time of patients
in group B was 22 (10–63) days. The mean GCS score of
patients in group B during discharge was 11.12 ± 1,867.
Fourteen patients were followed up for an average period
of 10.6 months. Three patients, one of whom did not visit
the hospital after the operation and two died due to heart
attack and pneumonia, were not followed. Three clinically
suitable patients underwent cranioplasty (Figures 2A, 2B,
2C, 2D). Of the patients who underwent DHC in group B,
those with right-side pathology had a better median mRS
score (median: 2, min-max:1–4). The median mRS score
of those with right MCA infarction in group B at the time
of discharge was significant (p = 0.001).
3.10. Outcome
The median age of the groups was not significant. The
median age of group B was 61 (44–79) years, and this
group included younger patients. All patients were
categorized as aged > 60 and < 60 years to investigate the
effect of age on patients with MCA infarction and the ones
who underwent DHC. The survival rate of MCA infarcted

Table 4. Comparison of the groups in terms of preoperative tPA, thrombectomy, and preoperative and
postoperative AC/AA treatments.
tPA
(p = 0.371)
(%)

Thrombectomy
(p = 0.004)
(%)

Preoperative
AC/AA treatment
(p = 0.363)
(%)

Postoperative
AC/AA treatment
(p = 0.023)
(%)

Group A
(n = 30)

33.3

46.7

66.7

60

Group B
(n = 17)

47.1

5.9

2.4

100

*AC/AA: Anticoagulant and Antiaggregant, tPA: Tissue plasminogen activator.
Note: The values were presented as n (%).

Figure 2. A 45-year-old patient underwent DHC due to right MCA infarction. Upon arrival at the hospital, his GCS was 14 and he had
right MCA infarction, shift and edema were observed on CT (A). Herniation improved after DHC (B). Encephalomalastic area was
observed on MRI 6 months later (C), and cranioplasty was performed (D). *DHC: Decompressive hemicraniectomy, MCA: Middle
cerebral artery, GCS: Glascow coma scale, CT: Computed tomography, MRI: Magnetic resonance imagine.
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patients aged <60 years was 61.5%, while it was 26.5% in
those aged > 60 years and it was significant (p = 0.041). The
median mRS of patients < 60 and > 60 years were 4 (1–6)
and 6 (1–6), respectively. The difference in mRS between
the age groups was significant (p = 0.018, Table 5). Patients
who underwent DHC were assessed in separate groups
of left and right MCA infarctions. The survival rate of
patients with right MCA infarction and who underwent
DHC was 34.6% and their median mRS score was 6 (1–6).
The survival rate of patients with left MCA infarction was
38.09%, and their median mRS score was 6 (3–6). The
effect of pathological side differences on the outcome and
mRS was not significant (p = 0.232).
4. Discussion
Large hemispheric infarctions are observed in 1%–10%
of the patients with supratentorial infarction [10]. Lifethreatening brain edema is usually seen between the
second and fifth day after the onset of stroke and the
prognosis for these patients is poor despite maximum
intensive care treatment [11,12]. The mortality rate of the
cases was 70%–80% in intensive care-based prospective
series [4,12]. So, the term “malignant” MCA infarction
is used for large cerebral infarctions that do not respond
to medical treatments such as sedation, hyperventilation,
steroid, barbiturate, glycerol and mannitol and various
conservative treatment strategies aimed at reducing brain
edema and ICP. In such cases where other treatments
are inadequate, DHC is a surgical treatment option that
reduces mortality by reducing ICP, stopping herniation
and increasing CBP. Preoperative ICP monitoring can
help decide the necessity of DHC. Postoperative ICP
monitoring is also useful to decide if additional treatment
is required.
DHC is generally performed using a one-sided approach
on the infarction side with which a bone flap of 15 × 15 cm
is removed [13]. The dura is incised and exposed or wide
duraplasty is performed. The brain expands from the skull
outward. In decompressive surgery, which involves only
bone removal, ICP decreases nearly by 15%, while this
decrease after DHC can increase to 70% if the dura is also

exposed [13,14]. We did not perform duraplasty or dura
exposure, and the dura of all patients were left open after
DHC in the present study. In terms of functional outcome
and mortality, there was no difference between duraplasty
or dura exposure via durotomy.
Many researchers have focused on this life-saving
surgical option in the last 20 years. They often drew attention
to DHC time and the effectiveness of the procedure
through age and functional outcomes. Although there are
different opinions, the younger patients have better results
than those aged ≥ 60 years [15]. However, the analysis of a
large Japanese database in which DHC patients aged > 60
years constituted 80% of the population, showed no agerelated differences [16]. The American Heart Association
and the American Stroke Association have recommended
DHC within the first 48 h, especially in cases of stroke
in people aged < 60 years [17]. The Neurocritical Care
Society and German Society for Neuro Intensive Care and
Emergency Medicine recommended DHC within 24–48 h
regardless of age [18]. Similar to our study, they stated that
patients > 60 years may be more likely to have a serious
disability. Of the patients who underwent DHC in our
study, the median age of the surviving patients was 61 (44–
79) years and it was 66.5 (37–80) in the deceased. Similar
to the literature, all patients aged > 60 and < 60 years were
re-evaluated, and young age had a significant impact on
survival. Performing DHC in stroke cases of young age
assisted in achieving better functional recovery.
Cardiac diseases lead to a stroke, which is possibly
caused by a cardio embolic stroke. Similar to our study, the
most common diseases in patients with MCA infarction
were HT, DM, hyperlipidemia and AF and these diseases
and smoking were important risk factors for stroke [5].
Comorbidity was directly associated with mortality and
functional outcome [19]. In the present study, 80.9% of
patients had HT, 27.7% CAD, 27.7% DM and 25.53% AF
and our data were in line with the literature.
Low GCS score, the poor state of consciousness and
anisocoria are indications for herniation. In a study by
Huh et al., patients with high preoperative GCS scores had
lower mortality rates and better functional outcomes [20].

Table 5. mRS and survival status of the patients by age.
Survival
(p = 0.041)
(%)

Age groups
(years)

n

< 60

13

61.5

> 60

34

26.5

mRS
(p = 0.018)
(Median (min-max))
4 (1–6)
6 (1–6)

*mRS: Modified Rankin scale.
Note: The values were presented as median (min-max) and n (%).
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Similarly, anisocoria was directly related to a bad outcome.
In our series, the absence of anisocoria before surgery and
the high GCS score at the time of admission increased the
chances of survival. Therefore, DHC should be performed
before pupil dilatation. Low GCS is a risk factor for
unassisted life after discharge in patients with stroke [21].
Some studies on acute stroke therapy investigate
the effect of time and urgent intervention that can limit
cerebral damage [22]. We reviewed the elapsed time until
hospitalization and access to medical treatment after
the onset of symptoms. The group of patients surviving
DHC had been hospitalized earlier, and early and rapid
treatment in ischemic stroke was of great importance.
Many previous DHC analyses recommend early
surgery [17,18]. We can associate it with the increased
survival owing to DHC performed before clinical
manifestations of herniation as in our study. DHC may be
more effective for functional recovery and survival if it’s
performed within the first 24 h following the onset of the
disease [1]. Schwab et al. reported a mortality rate of 16%
in the group operated in the first 21 h and a mortality rate
of 34.4% in the group operated in the first 39 h on average.
The rate of uncal herniation in the latter was 75%, while
it was 13% in the first [23]. Dasenbrock et al. analyzed a
large national database of 1300 patients who underwent
DHC [24]. They found that 56% of patients underwent
DHC within 48 h, and only the group operated 72 h after
the onset of stroke had worse results. However, there was
a significant relationship between the time, herniation and
outcome. Therefore, DHC is the most important temporal
factor before the development of herniation. This clinical
condition can be explained by increased cerebral edema
caused by deterioration and ICP that causes impaired
cerebral perfusion in the non-ischemic parenchyma as
part of a cascade, known as secondary brain damage [25].
The median elapsed time until surgery in patients in our
study was 44 (4–480) h; however, there was no significant
difference between the survivors and those deceased. The
positive effect of early hospital admission on survival was
significant. Accordingly, the time of admission and time
of surgery is the most important prognostic factors in
patients with MCA infarction.
Avoiding postoperative AC/AA treatment due to
the risk of hemorrhagic transformation or growing
hematoma in patients who underwent DHC and who
routinely use AC/AA medications may give rise to
other risks. All patients who undergo DHC should
be administered AC/AA treatment recommended by
neurologists and neurosurgeons to protect them from
fatal complications such as deep vein thrombosis,
pulmonary thromboembolism, acute coronary syndrome
and recurrent stroke. AC/AA treatment should be
provided at the neurosurgeons’ discretion. Subcutaneous

low-molecular-weight heparin may be administered to
prevent deep vein thrombosis despite the hemorrhagic
transformation on CT [18]. In our study, patients who
received AC/AA treatment during the post-operative
period had a lower mortality rate. Rapid reperfusion of
ischemic penumbra within 3 h from the onset of symptoms
with thrombolysis is a proven method of treatment n
acute stroke. Although more patients were administered
tPA in the surviving group, it was not significant. In the
literature, the rate of unsuccessful thrombectomy in
patients with acute stroke was 17% [26]. In our study, a
higher number of failed thrombectomy attempts were
noted in the deceased group and this was significant. This
could be associated with the development of vasospasm
after endovascular treatment or the continuation of ICP
elevation due to lack of recanalization. In their 690-case
series, Park et al. reported that 136 patients (19.7%) had
recanalization failure and most of patients with failed
endovascular intervention had poor outcomes [27].
Some guidelines are often referred to in the decision
of DHC. In the 2018 guide of the American Heart
Association and the American Stroke Association, DHC
is recommended for all patients with MCA infarction who
have neurological worsening within 48 h despite medical
treatment and regardless of age [28]. In our study, surgery
decisions were made by different surgeons based on only
radiological deterioration, only neurological deterioration
or both. None of them had any effect on mortality and
functional recovery.
DHC for malignant stroke has a significant preventive
effect on mortality [29]. In our study, the numbers of
patients with left and right MCA infarctions were almost
similar, and there was no difference in mortality rates.
Although it was not statistically different, patients with
right MCA infarction had better mean scores of mRS in
terms of functional outcome. This provided a different
view. In addition to its life-saving effect, DHC allowed
patients with MCA infarction in the dominant hemisphere
to live indirectly with moderate/severe disability. However,
this is a separate topic of discussion where some ethical
issues can be raised. Therefore, having precise information
about the relevant data is crucial for patients in the
decision-making process and such data should be shared
with patients’ relatives while deciding on DHC. It can be
difficult to decide who is a candidate for early or urgent
surgery and whether surgical delay might be beneficial
until clear evidence is found. It might be even more
difficult to determine if the patient will have acceptable
disability and quality of life different from the predicted
based on preoperative estimates [29].
Despite being relatively simple, DHC is a demanding
surgical procedure since it has significant complications.
Complications of DHC increased in patients with
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advanced age, taking ASA or other anticoagulants [30].
The development of postoperative hematoma or increase
in existing hemorrhage due to the routine previous
use of AC/AA treatment or the administration of this
treatment in NICU during the preoperative period can be
considered as the most important complications. Surgical
site problems and CSF fistula can be considered as other
minor complications due to surgery. In our study, no
patients developed hematoma requiring surgical treatment
after DHC. However, three patients had surgical wound’s
problems.
5. Conclusion
To conclude, age, DHC time and elapsed time until
hospitalization or access to treatment are directly related
to the functional outcome and survival. To increase
survival, patients with MCA infarction should be
administered medical treatment and DHC once herniation
is detected radiologically without waiting for neurological

deterioration (anisocoria, low GCS score). Other lifethreatening complications can be avoided with proper AC/
AA treatment after DHC.
Limitations
Cranioplasty could not be performed in some patients
and were not followed in the long-term due to their city of
residence or economic condition.
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